Serpil Yanık Çolak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Serpil Yanık Çolak has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Burak Andaç
Department of Internal Medicine, Division of Endocrinology and Metabolism, Faculty of Medicine, Trakya University, 22030 Edirne, Türkiye
3 shared publications - Mehmet Celik
Department of Internal Medicine, Division of Endocrinology and Metabolism, Faculty of Medicine, Trakya University, 22030 Edirne, Türkiye
3 shared publications - Buket Yilmaz Bulbul
Department of Endocrinology and Metabolism , Trakya University School of Medicine , Edirne , Türkiye
2 shared publications - Eray Özgün
Department of Medical Biochemistry , 37521 Trakya University School of Medicine , Edirne , Türkiye
2 shared publications - Mine Okur
Trakya Universitesi, Tip Fakultesi
2 shared publications - Ali Cem Yekdeş
Trakya Universitesi
1 shared publication
Latest Publications
- Open Access
The Relationship Between Serum MG53 Levels and the Presence of Metabolic Syndrome and Its Components
Background and Objectives: MG53 is a myokine/cardiokine involved in membrane repair. Some preclinical studies suggest that it is associated with insulin resistance. Metabolic syndrome (MS) is manifested by dyslipidemia, hypertension (HT), visceral obesity, hyperinsulinism, and glucose intolerance. We aimed to evaluate the relationship between the MG53 protein and MS and its components. Materials and Methods: This study was conducted among 64 patients with MS and 64 age- and sex-matched healthy participants. MG53 levels were measured using Human-MG53, a commercially available enzyme-linked immunosorbent assay (ELISA) kit (Cat# CSB-EL024511HU, Alfagen laboratory supplies, Cusabio, Bornova, İzmir.). Results: There was no significant connection between serum MG53 levels and the presence of MS (p = 0.969). We found no correlation between serum MG53 levels and the presence of HT, weight, waist circumference, body mass index, HDL-C, fasting blood glucose, and HbA1c levels. Conclusions: This study’s results suggest no association between serum MG53 levels and MS parameters in the studied ethnic population. Due to the limited number and controversy of available studies on this subject, our findings may provide perspective for conducting studies with more diverse populations to obtain more comprehensive results.
Open AccessThe Relationship Between Serum MG53 Levels and the Presence of Metabolic Syndrome and Its Components
Background and Objectives: MG53 is a myokine/cardiokine involved in membrane repair. Some preclinical studies suggest that it is associated with insulin resistance. Metabolic syndrome (MS) is manifested by dyslipidemia, hypertension (HT), visceral obesity, hyperinsulinism, and glucose intolerance. We aimed to evaluate the relationship between the MG53 protein and MS and its components. Materials and Methods: This study was conducted among 64 patients with MS and 64 age- and sex-matched healthy participants. MG53 levels were measured using Human-MG53, a commercially available enzyme-linked immunosorbent assay (ELISA) kit (Cat# CSB-EL024511HU, Alfagen laboratory supplies, Cusabio, Bornova, İzmir.). Results: There was no significant connection between serum MG53 levels and the presence of MS (p = 0.969). We found no correlation between serum MG53 levels and the presence of HT, weight, waist circumference, body mass index, HDL-C, fasting blood glucose, and HbA1c levels. Conclusions: This study’s results suggest no association between serum MG53 levels and MS parameters in the studied ethnic population. Due to the limited number and controversy of available studies on this subject, our findings may provide perspective for conducting studies with more diverse populations to obtain more comprehensive results.
- 1 January 2024
- Published by Kare Publishing in Eurasian Journal of Medical Advances
- Vol. 4 (3) , 170-175
Retrospective Analysis of Factors Impairing Glycemic Control in Type 2 Diabetics on Intensive Insulin Therapy with HbA1c Levels of 10% or Above (Single-Center Experience)
Objectives: In this study, we aimed to investigate the effects of factors related to lifestyle, treatment compliance, and eating habits on blood glucose regulation in patients diagnosed with Type 2 DM (Diabetes Mellitus) with HbA1c 10% and above who are receiving intensive insulin therapy. Methods: The study sample consisted of 100 diabetic patients with inadequate glycemic control who applied to our clinic between January 2015 and December 2016. A questionnaire developed by the researchers was used in the study. The patients' sociodemographic and anthropometric characteristics, eating habits, compliance with insulin treatment, physical activity, and dental health data were documented. Results: Of the patients included in our study, 75% were female and 25% were male, the average age was 60, the average HbA1c was 12.3%, and the average Body Mass Index was 31.7 kg/m2. While 88% of our patients stated that they had three main meals a day, 12% stated that they skipped at least one main meal, and 64% had irregular eating habits. Forty percent of our patients skipped insulin doses at least 1-2 times a week, and there was a statistically significant relationship between the frequency of insulin dose skipping and HbA1c subgroups (p=0.014). Sixty-seven percent of our patients did not exercise daily. Conclusion: Although education level, eating habits, exercise, and dental health are among the variables affecting glycemic control in diabetic patients, the most critical factor affecting glycemic control in our study group was a lack of compliance with insulin injection.
- 1 January 2024
- Published by Kare Publishing in Eurasian Journal of Medical Advances
- Vol. 4 (3) , 170-175
Retrospective Analysis of Factors Impairing Glycemic Control in Type 2 Diabetics on Intensive Insulin Therapy with HbA1c Levels of 10% or Above (Single-Center Experience)
Objectives: In this study, we aimed to investigate the effects of factors related to lifestyle, treatment compliance, and eating habits on blood glucose regulation in patients diagnosed with Type 2 DM (Diabetes Mellitus) with HbA1c 10% and above who are receiving intensive insulin therapy. Methods: The study sample consisted of 100 diabetic patients with inadequate glycemic control who applied to our clinic between January 2015 and December 2016. A questionnaire developed by the researchers was used in the study. The patients' sociodemographic and anthropometric characteristics, eating habits, compliance with insulin treatment, physical activity, and dental health data were documented. Results: Of the patients included in our study, 75% were female and 25% were male, the average age was 60, the average HbA1c was 12.3%, and the average Body Mass Index was 31.7 kg/m2. While 88% of our patients stated that they had three main meals a day, 12% stated that they skipped at least one main meal, and 64% had irregular eating habits. Forty percent of our patients skipped insulin doses at least 1-2 times a week, and there was a statistically significant relationship between the frequency of insulin dose skipping and HbA1c subgroups (p=0.014). Sixty-seven percent of our patients did not exercise daily. Conclusion: Although education level, eating habits, exercise, and dental health are among the variables affecting glycemic control in diabetic patients, the most critical factor affecting glycemic control in our study group was a lack of compliance with insulin injection.
- 8 December 2023
- Published by Galenos Yayinevi in Namık Kemal Tıp Dergisi
- Vol. 11 (4) , 395-399
Falsely Elevated Thyroid Stimulating Hormone in Two Cases Requiring Special Follow-up
- 8 December 2023
- Published by Galenos Yayinevi in Namık Kemal Tıp Dergisi
- Vol. 11 (4) , 395-399
Falsely Elevated Thyroid Stimulating Hormone in Two Cases Requiring Special Follow-up
- Open Access
- 31 October 2023
- Published by Akdeniz University in Akdeniz Medical Journal
- Vol. 10 (2) , 284-288
25-Hydroxyvitamin D Status In Type 1 Diabetic Adults And Its Relationship With Glycemic Control
Objective: To assess the vitamin D levels between adults with type 1 diabetes mellitus and the healthy control group and evaluate the relationship between HbA1c levels and vitamin D status in the diabetic group. Methods: Our cross-sectional, descriptive study included 98 type 1 diabetic patients over 18 years old who applied to the Endocrinology Outpatient Clinic and 95 age- and sex-matched individuals without chronic disease. Patients with advanced renal or liver disorders, primary hyperparathyroidism, metabolic bone disorders, or using medications that might change vitamin D concentrations were excluded from the study. HbA1c and 25(OH) Vitamin-D3 levels were measured three times in 9 months, and the average of the measurements was used. Diabetic patients and control individuals were separated into three groups according to their vitamin D levels as follows: deficiency ( 20 ng/ml). Results: Serum 25 (OH) vitamin D levels of diabetic patients were significantly lower than in healthy individuals (p=0.024). However, when diabetic adults were separated into three groups according to 25(OH) vitamin D levels, there was no significant difference regarding HbA1c levels (p=0.905). Conclusion: Although preclinical data support the role of low serum vitamin D levels in the etiopathogenesis of type 1 diabetes mellitus, studies examining the connection between low serum vitamin D levels and the prevalence of type 1 diabetes or glycemic control are not sufficient to reach a clear conclusion, including our study.
- 31 October 2023
- Published by Akdeniz University in Akdeniz Medical Journal
- Vol. 10 (2) , 284-288
Open Access25-Hydroxyvitamin D Status In Type 1 Diabetic Adults And Its Relationship With Glycemic Control
Objective: To assess the vitamin D levels between adults with type 1 diabetes mellitus and the healthy control group and evaluate the relationship between HbA1c levels and vitamin D status in the diabetic group. Methods: Our cross-sectional, descriptive study included 98 type 1 diabetic patients over 18 years old who applied to the Endocrinology Outpatient Clinic and 95 age- and sex-matched individuals without chronic disease. Patients with advanced renal or liver disorders, primary hyperparathyroidism, metabolic bone disorders, or using medications that might change vitamin D concentrations were excluded from the study. HbA1c and 25(OH) Vitamin-D3 levels were measured three times in 9 months, and the average of the measurements was used. Diabetic patients and control individuals were separated into three groups according to their vitamin D levels as follows: deficiency ( 20 ng/ml). Results: Serum 25 (OH) vitamin D levels of diabetic patients were significantly lower than in healthy individuals (p=0.024). However, when diabetic adults were separated into three groups according to 25(OH) vitamin D levels, there was no significant difference regarding HbA1c levels (p=0.905). Conclusion: Although preclinical data support the role of low serum vitamin D levels in the etiopathogenesis of type 1 diabetes mellitus, studies examining the connection between low serum vitamin D levels and the prevalence of type 1 diabetes or glycemic control are not sufficient to reach a clear conclusion, including our study.